Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Intestinal VLP metagenomes from at-risk RA individuals

ABSTRACT: Intestinal VLP reads and predicted phage contigs for at-risk RA individuals

PROVIDER: PRJEB42612 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	ERR5169580_1.fastq.gz	Fastqsanger.gz
	ERR5169580_2.fastq.gz	Fastqsanger.gz
	ERR5169900_1.fastq.gz	Fastqsanger.gz
	ERR5169900_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 101

Similar Datasets

CHIKV VLP Vaccination in Humans induced broadly neutralizing antibodies

Project description:VLP Vaccination in humans induced antigen-specific B cells with broad reactivity and protection in mouse models of infection

2023-03-31 | GSE218843 | GEO

human gut vlp test

Project description:human gut vlp test Metagenome

| PRJNA817901 | ENA

Inflammation and lymphocyte activation during longitudinal progression to rheumatoid arthritis in at-risk individuals

Project description:Rheumatoid Arthritis is a chronic immune-mediated disease characterized by joint inflammation, autoantibodies, and systemic inflammatory features. Autoantibodies, including anti-citrullinated protein antibodies are highly predictive biomarkers that pre-date clinical disease and can be used to identify individuals “at-risk” for RA. We performed a prospective, longitudinal multi omic study of at-risk individuals at multiple timepoints to characterize their immune state. One-third of patients progressed to clinically active RA during the study. We show that at-risk RA subjects have systemic inflammation with features like those observed in active RA despite having no clinical disease. Progression to active disease was especially apparent in the T and B cells compartments, with pro-pathogenic features recognized in naive cells. We identify key molecular and cellular alterations in innate and adaptive immunity that accompany this inflammatory state.

2025-09-12 | GSE274680 | GEO

Gene Expression Patterns Induced by HPV-16 L1 VLP in Leukocytes from Vaccine Recipients

Project description:Human papilloma (HPV) virus-like particle (VLP) vaccines were recently licensed. Though neutralizing antibody titers are thought to be the main effectors of protection against infection, early predictors of long-term efficacy are not yet defined and a comprehensive understanding of innate and adaptive immune responses to vaccination is still lacking. Here, microarrays were used to compare the gene expression signature in HPV-16 L1 VLP-stimulated PBMC from 17 vaccine and 4 placebo recipients before vaccination, and 1 month after receiving the second immunization. Vaccination with HPV-16 L1 VLP was associated with modulation of genes involved in the inflammatory/defense response, cytokine, interferon and cell cycle pathways in VLP-stimulated PBMC. In addition, there was up-regulation of probesets associated with cytotoxic (GZMB, TNFSF10) and regulatory (INDO, CTLA4) activities. The strongest correlations with neutralizing antibody titers were found for cyclin d2 (CCND2) and galectin (LGALS2). Twenty-two differentially expressed probesets were selected for confirmation by RT-PCR in an independent sample set. Agreement with the microarray data was seen for over two-thirds of these probesets. Up-regulation of immune/defense response genes by VLP, in particular interferon-induced genes was observed in PBMC collected prior to vaccination, with many of these genes being further induced following vaccination. In conclusion, we used gene expression profiling to identify important innate and adaptive response related- genes induced by vaccination with HPV VLP. Further studies are needed to identify gene expression signatures of immunogenicity and long-term protection with potential utility in prediction of long-term HPV vaccination outcomes in clinical trials. Keywords: Time course - pre and post HPV immunizaton

2008-11-14 | GSE13587 | GEO

human gut metagenomics VLP reads

Project description:human gut metagenomics VLP reads

| PRJNA648797 | ENA

Rhodothermaceae bacterium RA strain:RA

Project description:Rhodothermaceae bacterium RA strain:RA Genome sequencing

| PRJNA308615 | ENA

Phosphoproteome of RA-responsive and RA-resistant breast cancer cell lines

Project description:Retinoic acid (RA), the main active vitamin A metabolite, controls multiple biological processes such as cell proliferation and differentiation through genomic programs and kinase cascades activation. Due to these properties, RA has proven anti-cancer capacity. Several breast cancer cells respond to the antiproliferative effects of RA, while others are RA-resistant. However, the overall signaling and transcriptional pathways that are altered in such cells have not been elucidated. Here, in a large-scale analysis of the phosphoproteins and in a genome-wide analysis of the RA-regulated genes, we compared two human breast cancer cell lines, a RA-responsive one, the MCF7 cell line, and a RA-resistant one, the BT474 cell line, which depicts several alterations of the "kinome".

2016-07-05 | PXD004357 | Pride

Phosphoproteome of RA-responsive and RA-resistant breast cancer cell lines

2020-10-15 | PXD005911 | Pride

Population RNA Seq of enriched human peripheral blood monocytes treated with at-RA/4-oxo-RA/DMSO for 24h in culture

Project description:Study of the effects of at-RA and 4-oxo-RA 72h treatment on the transcriptome of human peripheral blood monocytes from healthy individuals.

2025-02-06 | E-MTAB-14660 | biostudies-arrayexpress

Project description:WTCCC1 project Rheumatooid arthritis (RA) samples

| EGAD00000000007 | EGA